These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12135583)

  • 1. Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children.
    Esposito S; Principi N
    Drug Resist Updat; 2002 Apr; 5(2):73-87. PubMed ID: 12135583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide guidelines for respiratory tract infections: community-acquired pneumonia.
    Dalhoff K
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S39-44. PubMed ID: 11574194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
    Rapp RP
    Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old and new antibiotics for pediatric pneumonia.
    Bradley JS
    Semin Respir Infect; 2002 Mar; 17(1):57-64. PubMed ID: 11891519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
    He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
    BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the challenge of antibiotic resistance: The PROTEKT US study.
    Stratton CW
    Postgrad Med; 2002 Sep; 112(3 Suppl):7-11. PubMed ID: 19667589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children.
    Cunha BA
    Infection; 2004 Apr; 32(2):98-108. PubMed ID: 15057574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
    Garau J
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):83-99. PubMed ID: 15696306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.
    Low DE; Pichichero ME; Schaad UB
    Clin Pediatr (Phila); 2004 Mar; 43(2):135-51. PubMed ID: 15024437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
    Poirier R
    Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic-Resistant Community-Acquired Bacterial Pneumonia.
    Ho J; Ip M
    Infect Dis Clin North Am; 2019 Dec; 33(4):1087-1103. PubMed ID: 31668192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics in childhood pneumonia.
    Hale KA; Isaacs D
    Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of pathogens causing community-acquired pneumonia.
    Feldman C; Anderson R
    Semin Respir Crit Care Med; 2012 Jun; 33(3):232-43. PubMed ID: 22718209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric therapy of community-acquired pneumonia.
    Green DS; San Pedro GS
    Semin Respir Infect; 2000 Sep; 15(3):227-33. PubMed ID: 11052423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
    Bogdanov MB; Chernen'kaia TV
    Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.